FDA considers broad package insert labeling overhaul
The FDA may require nationwide labeling changes across most drugs via new guidelines. Proposals aim to tighten claims, expand warnings, and introduce drug of choice notes while expanding pediatric dosing data and comparative statements. Changes would be phased in over time with expert consultation and category-based review.